Advanced Biomed Inc. Acquires Acellent Technologies (Hong Kong) Co. Limited

Advanced Biomed Inc. has entered into a Share Purchase Agreement to acquire 100% of the equity interest in Acellent Technologies (Hong Kong) Co. Limited. The Target company specializes in AI-powered financial verification and audit solutions. The total purchase price is 270,000 shares of Advanced Biomed Inc.’s common stock, valued at an estimated $4.00 per share, totaling $1,080,000. The acquisition is contingent upon the completion of financial and legal due diligence and the receipt of all necessary regulatory approvals. This agreement was executed on April 2, 2026.